ATE191850T1 - Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung - Google Patents

Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Info

Publication number
ATE191850T1
ATE191850T1 AT94900557T AT94900557T ATE191850T1 AT E191850 T1 ATE191850 T1 AT E191850T1 AT 94900557 T AT94900557 T AT 94900557T AT 94900557 T AT94900557 T AT 94900557T AT E191850 T1 ATE191850 T1 AT E191850T1
Authority
AT
Austria
Prior art keywords
oak bark
bark extract
ions
methods
extract
Prior art date
Application number
AT94900557T
Other languages
English (en)
Inventor
David N S Hon
R Thomas Stanley
Original Assignee
Greystone Medical Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Greystone Medical Group Inc filed Critical Greystone Medical Group Inc
Application granted granted Critical
Publication of ATE191850T1 publication Critical patent/ATE191850T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Laminated Bodies (AREA)
  • Road Paving Structures (AREA)
  • Cosmetics (AREA)
AT94900557T 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung ATE191850T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97307192A 1992-11-06 1992-11-06
PCT/US1993/010670 WO1994011010A2 (en) 1992-11-06 1993-11-04 Compositions of oak bark extract, related synthetic compositions, and method of using same

Publications (1)

Publication Number Publication Date
ATE191850T1 true ATE191850T1 (de) 2000-05-15

Family

ID=25520460

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94900557T ATE191850T1 (de) 1992-11-06 1993-11-04 Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung

Country Status (21)

Country Link
US (1) US6149947A (de)
EP (1) EP0668769B1 (de)
JP (1) JP3640215B2 (de)
AT (1) ATE191850T1 (de)
AU (1) AU700019B2 (de)
BR (1) BR9307401A (de)
CA (1) CA2148795C (de)
CY (1) CY2231B1 (de)
CZ (1) CZ117395A3 (de)
DE (1) DE69328438T2 (de)
DK (1) DK0668769T3 (de)
ES (1) ES2147780T3 (de)
HU (1) HUT73791A (de)
MX (1) MX9306960A (de)
NO (1) NO951740L (de)
NZ (1) NZ258019A (de)
OA (1) OA10153A (de)
PL (1) PL308770A1 (de)
PT (1) PT668769E (de)
WO (1) WO1994011010A2 (de)
ZA (1) ZA938274B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014870B1 (en) * 1992-11-06 2006-03-21 Greystone Medical Group, Inc. Compositions of oak bark extract related synthetic compositions and method of using same
AUPN104895A0 (en) * 1995-02-10 1995-03-09 Lai, John Methods of and preparations for the treatment of ailments and disorders
US20040037898A1 (en) * 1997-10-08 2004-02-26 Hon David N.S Compositions of oak bark extract, related synthetic compositions and method of using same
US20050033251A1 (en) * 1998-12-08 2005-02-10 Quick-Med Technologies, Inc. Controlled release of biologically active substances from select substrates
JP2005515191A (ja) * 2001-11-29 2005-05-26 グレイストーン メディカル グループ、インコーポレイテッド 創傷の治療及び使用する組成物
US20040170703A1 (en) * 2001-11-29 2004-09-02 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
US6667026B1 (en) 2002-03-15 2003-12-23 Pocono Falls, Inc. Allergic contact dermatitis treatment and composition therefor
WO2003099218A2 (en) * 2002-05-24 2003-12-04 Greystone Medical Group, Inc. Anti-cancer formulation
AU2003303335A1 (en) * 2002-12-23 2004-07-22 Greystone Medical Group, Inc. Reduction of reactive oxygen species in chronic wound management
WO2005000328A1 (en) * 2003-06-24 2005-01-06 Zanti Gianfranco Compositions based on plant ash for the treatment of skin diseases
US20060105017A1 (en) * 2004-06-22 2006-05-18 Greystone Medical Group, Inc. Methods for treatment of wounds using time release compositions
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
AU2006337161B2 (en) 2006-02-03 2012-06-07 Obagi Cosmeceuticals Llc Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
EP2173363B1 (de) * 2007-03-15 2016-12-07 Om Kataria Gebärmutter-stimulierende stäbchen
ES2652114T3 (es) 2007-10-15 2018-01-31 7 Oaks Pharmaceutical Corporation Una disolución que contiene silicato para uso en el tratamiento de melanoma
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
WO2010085753A1 (en) 2009-01-23 2010-07-29 Jr Chem, Llc Rosacea treatments and kits for performing them
US20110200655A1 (en) * 2010-02-16 2011-08-18 Michael Darryl Black Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US8828449B2 (en) 2012-01-26 2014-09-09 Libby Robinson Wound dressing composition and method of use
US9351995B1 (en) 2011-04-29 2016-05-31 Red Oax Holdings, LLC Compositions and methods of enhancing wound healing
JP2014520657A (ja) * 2011-07-20 2014-08-25 スリーエム イノベイティブ プロパティズ カンパニー イオン担持組成物を含んだ包帯
EP2736486B1 (de) * 2011-07-28 2019-03-06 3M Innovative Properties Company Wundheilende zusammensetzungen und verwendungsverfahren dafür
CN103732192B (zh) 2011-08-17 2016-03-16 3M创新有限公司 单体接枝纤维及其用途
GB201402672D0 (en) 2014-02-14 2014-04-02 Medical Res Council Materials and methods relating to stabilised polymeric silicate compositions
WO2016123539A1 (en) 2015-01-29 2016-08-04 Wardell Mark R Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use
CN113785067B (zh) * 2019-03-04 2024-01-16 奥瑞丽斯治疗股份公司 氯化物诱导型原核表达系统
IT201900018047A1 (it) * 2019-10-07 2021-04-07 Nello Vallicella Procedimento per la preparazione di una composizione topica liquida.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US256847A (en) * 1882-04-25 Salve
US55911A (en) * 1866-06-26 Improved medical compound
US37901A (en) * 1863-03-17 Improved liniment
US202246A (en) * 1878-04-09 Improvement in medical compounds
DE819127C (de) * 1949-09-28 1951-10-29 Heinz Dr Bauer Verfahren zur Herstellung eines Heilbades gegen Hautekzeme
DE812341C (de) * 1950-03-07 1951-08-27 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung eines Hautbehandlungsmittels
DE833840C (de) * 1950-06-01 1952-03-13 Dr Heinz Bauer Verfahren zur Herstellung einer Salbe gegen Hautekzeme
US3928584A (en) * 1969-06-30 1975-12-23 Us Health Education & Welfare Extracts from active tree saps for treating P388 mouse leukemia
US4059695A (en) * 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
JPS60164467A (ja) * 1984-02-07 1985-08-27 Rooman Kogyo:Kk 飲料
DE3584837D1 (de) * 1985-10-08 1992-01-16 Psori Med Ag Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4847083A (en) * 1986-04-02 1989-07-11 Dermasciences, Inc. Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith
BE1000950A3 (fr) * 1987-10-05 1989-05-23 Claude Patricia Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence.
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5080900A (en) * 1990-04-17 1992-01-14 Stanley R Thomas Treatment of skin ulcers with an aqueous extract of oak bark ash

Also Published As

Publication number Publication date
AU700019B2 (en) 1998-12-17
CA2148795C (en) 2004-08-10
NZ258019A (en) 1998-12-23
MX9306960A (es) 1995-01-31
PT668769E (pt) 2000-10-31
CY2231B1 (en) 2003-04-18
CA2148795A1 (en) 1994-05-26
DE69328438T2 (de) 2001-01-04
ZA938274B (en) 1994-06-09
EP0668769A1 (de) 1995-08-30
AU5550094A (en) 1994-06-08
BR9307401A (pt) 1999-08-24
DE69328438D1 (de) 2000-05-25
PL308770A1 (en) 1995-08-21
WO1994011010A3 (en) 1994-09-15
CZ117395A3 (en) 1995-11-15
US6149947A (en) 2000-11-21
HU9501323D0 (en) 1996-05-28
HUT73791A (en) 1996-09-30
WO1994011010A2 (en) 1994-05-26
DK0668769T3 (da) 2000-10-02
ES2147780T3 (es) 2000-10-01
JP3640215B2 (ja) 2005-04-20
NO951740L (no) 1995-06-19
EP0668769B1 (de) 2000-04-19
NO951740D0 (no) 1995-05-04
OA10153A (en) 1996-12-18
JPH08503462A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
ATE191850T1 (de) Eichenrindenextraktverwandte synthetische zubereitungen und verfahren zur verwendung
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2033434T3 (es) Composicion cosmetica.
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
WO1994011010B1 (en) Compositions of oak bark extract, related synthetic compositions, and method of using same
DE69132048T2 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
AU6998787A (en) Transglutaminase inhibitors
ATE225340T1 (de) Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE83378T1 (de) Verwendung von 3'-azido-deoxythymidin zur herstellung eines arzneimittels zur behandlung von humanen brustcarzinomen.
DE69026511T2 (de) Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE69232852T2 (de) Verwendung von topotecan in der behandlung von nichtkleinzelligen lungenkarzinomen
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
ATE107166T1 (de) Verwendung von chlormethiazol zur herstellung eines artzneimittels zur prophylaxe oder therapie der neurodegeneration.
IT1199960B (it) Agenti stimolanti la crescita dei capelli e loro impiego
ATE77952T1 (de) Verwendung von 1,4-dihydropyridinderivaten.
MX9405923A (es) Mejoras en proceso para humectar y suavizar la piel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee